Inventor · disambiguated record
Mark Alfonso
Also filed as: ALFONSO MARK · ALFONSO MARK A
5 granted patents·8 pending applications·108 citations·filing 1995–2014
78Inventor score
Top patents by PatentIndex Score
13 records- 0191US6017963AFormulation for intranasal administrationEURO CELTIQUE SA·Filed 1995·Granted Jan 25, 2000·89 cites·11 claims
- 0282US6642275B2Formulation for respiratory tract administrationEURO CELTIQUE SA·Filed 2001·Granted Nov 4, 2003·14 cites·12 claims
- 0369US7018649B2Felodipine transdermal device and methodsEURO CELTIQUE SA·Filed 2001·Granted Mar 28, 2006·5 cites·37 claims
- 0458US2014199383A1Abuse resistant opioid containing transdermal systemsPURDUE PHARMA LP·Filed 2014·Application pending·0 cites
- 0556US2005031678A1Terazosin transdermal device & methodsEURO CELTIQUE SA·Filed 2004·Application pending·0 cites
- 0652US2008262284A1Disposal system for transdermal dosage formPURDUE PHARMA LP·Filed 2008·Application pending·0 cites
- 0751US2004146547A1Disposal system for transdermal dosage formFiled 2002·Application pending·0 cites
- 0850US2004241218A1Abuse resistant opioid containing transdermal systemsFiled 2002·Application pending·0 cites
- 0949US2015182474A1Disposal system for transdermal dosage formPURDUE PHARMA LP·Filed 2014·Application pending·0 cites
- 1046US2002198215A1Terazosin transdermal device and methodsFiled 2001·Application pending·0 cites
- 1139US8496960B2Terazosin transdermal device and methodsTAVARES LINO·Filed 2002·Granted Jul 30, 2013·0 cites·18 claims
- 1237US9259397B2Loratadine transdermal device and methodsTAVARES LINO·Filed 2001·Granted Feb 16, 2016·0 cites·39 claims
- 1331US2001049391A1Formulations for respiratory tract administrationFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →